Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: LCZ696 vs Valsartan for Functional Mitral Regurgitation
NCT02687932Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Mar 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in mitral valve insufficiency (MR), left ventricular dysfunction, sponsored by Asan Medical Center. Started Mar 2016; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
mitral valve insufficiency (MR)left ventricular dysfunction
Beyond the preview
Go deeper on NCT02687932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687932.